Literature DB >> 26484614

Frailty and geography: should these two factors be added to the ABCDE contemporary guide to diabetes therapy?

Ernesto Maddaloni1, Luca D'Onofrio1, Paolo Pozzilli1,2.   

Abstract

On the road towards personalized treatments for type 2 diabetes, we suggest here that two parameters could be added to the ABCDE algorithm, 'F' for frailty and 'G' for geography. Indeed, the progressive ageing of population is causing a simultaneous increase of frailty worldwide. The identification of the optimal therapeutic approach is often difficult in frail subjects because of the complexity of 'frailty syndrome'. Nevertheless, given the relevance of diabetes in the development and progression of frailty, a safe and effective cure of diabetes is extremely important to guarantee a good medical outcome. There are few data about diabetes treatment in this delicate category of patients, and the choice of the appropriate therapy mostly remains a challenge. Moreover, type 2 diabetes affects more than 382 million people of different countries, races and ethnicities. To face the lack of solid evidence-based medicine for the treatment of diabetes in different ethnic groups, it is extremely important to increase knowledge about the different pathophysiology of diabetes according to ethnicity. In this way, a tailored approach to treatment of various ethnic groups living in the same or different regions can eventually be developed.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26484614     DOI: 10.1002/dmrr.2762

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  6 in total

1.  Diabetes: the disease of the 10 D.

Authors:  Ernesto Maddaloni; Paolo Pozzilli
Journal:  Endocrine       Date:  2017-10-26       Impact factor: 3.633

Review 2.  "H" for Heterogeneity in the Algorithm for Type 2 Diabetes Management.

Authors:  Pieralice Silvia; Zampetti Simona; Maddaloni Ernesto; Buzzetti Raffaella
Journal:  Curr Diab Rep       Date:  2020-03-20       Impact factor: 4.810

3.  Explanations for less small fibre neuropathy in South Asian versus European subjects with type 2 diabetes in the UK.

Authors:  Hassan Fadavi; Mitra Tavakoli; Philip Foden; Maryam Ferdousi; Ioannis N Petropoulos; Maria Jeziorska; Nishi Chaturvedi; Andrew J M Boulton; Rayaz A Malik; Caroline A Abbott
Journal:  Diabetes Metab Res Rev       Date:  2018-08-09       Impact factor: 4.876

Review 4.  Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine.

Authors:  Gaia Chiara Mannino; Francesco Andreozzi; Giorgio Sesti
Journal:  Diabetes Metab Res Rev       Date:  2019-01-07       Impact factor: 4.876

5.  The Impact of and Interaction between Diabetes and Frailty on Psychosocial Wellbeing and Mortality in Ireland.

Authors:  Mark O'Donovan; Duygu Sezgin; Rónán O'Caoimh; Aaron Liew
Journal:  Int J Environ Res Public Health       Date:  2020-12-19       Impact factor: 3.390

6.  Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II).

Authors:  Ernesto Maddaloni; Luca D'Onofrio; Francesco Alessandri; Carmen Mignogna; Gaetano Leto; Giuseppe Pascarella; Ivano Mezzaroma; Miriam Lichtner; Paolo Pozzilli; Felice Eugenio Agrò; Monica Rocco; Francesco Pugliese; Andrea Lenzi; Rury R Holman; Claudio Maria Mastroianni; Raffaella Buzzetti
Journal:  Cardiovasc Diabetol       Date:  2020-10-01       Impact factor: 9.951

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.